Medical Science Liaison Germany - North

Join to apply for the Medical Science Liaison Germany - North role at Apellis Pharmaceuticals

Summary

The Apellis MSL (Medical Science Liaison) is a remote role focused on developing and maintaining peer‑to‑peer scientific relationships with key medical experts. This role will primarily support the Apellis ophthalmology program and is embedded in the Medical Affairs department. The MSL will collaborate with physicians and other health care professionals to support trial enrolment, provide program and protocol training and ensure up‑to‑date medical information based on scientific exchange.

• Develop and maintain peer‑to‑peer collaborations and relationships with key medical experts in the ophthalmology community
• Support medical affairs (e.g., scientific exchange, conference support) and clinical development initiatives (e.g., site identification, trial recruitment)
• Collaborate with physicians on medical affairs initiatives including publications, advisory boards, medical education opportunities, training
• Serve as scientific peer‑to‑peer resource to external disease experts and internal stakeholders
• Support the medical community with up‑to‑date medical information, robust disease expertise, and product information
• Communicate clinical insights on new data to Apellis Medical Affairs and to inform medical strategy for the therapeutic area
• Train internal stakeholders on key scientific and medical topics in relevant therapeutic area
• Develop an understanding of the regional landscape including specialties involved in care of patients
• Maintain effective and appropriate communication among internal stakeholders while maintaining full compliance with relevant requirements
• Generate tactical regional plans to provide needs‑based, value‑added support of the medical and scientific community in‑line with company goals
• Uses systems to strategically map, identify, profile and prioritize thought leaders in line with the medical plan and goals
• Maintain accurate reporting and documentation of MSL activities
• Collaborate with internal cross‑functional stakeholders (e.g., Commercial, Access)

• Advanced scientific or clinical degree (MD, Pharm
  
  D, PhD, OD)
• At least 3 - 5 years of experience in Medical Affairs or Medical Science role
• Robust and current clinical development experience supporting drugs to treat rare diseases; prior ophthalmology experience preferred
• Candidates must have well‑established networks and active relationships with KOLs in the ophthalmology community in Germany
• Candidate must have an understanding of compliance considerations and demonstrate ability to work compliantly in a field‑based role, within the medical organization, as well as across the commercial organization

• Excellent oral and written communication skills in German and English
• Energetically embraces responsibilities, demonstrates ability to achieve goals
• Has strong initiative, and functions well as part of a cross‑functional team
• Exhibits excellent time management
• Demonstrated ability to work independently
• Experience in a start‑up environment preferred
• Must be pro‑active team player, flexible, and ability to work in dynamic situations

Office is home based.

Travel within region up to 75%. Required travel to medical meetings, team meetings, and other group meetings (will require some weekends).

Apellis offers a comprehensive benefits package, inclusive family building benefits, flexible time off, summer and winter shutdowns, paid family leave, disability and life insurance, and more!

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life‑changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3‑targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first‑ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC‑MPGN, two severe, rare kidney diseases.

We believe we have only begun to unlock the potential of targeting C3 across many serious diseases.

Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice.